Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP

Detalles Bibliográficos
Autores principales: Anthi, Anastasia, Stagaki, Eleni, Rallidis, Loukianos, Konstantonis, Dimitrios, Evangelopoulos, Maria-Eleftheria, Voumvourakis, Konstantinos, Armaganidis, Apostolos, Orfanos, Stylianos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073410/
https://www.ncbi.nlm.nih.gov/pubmed/32201683
http://dx.doi.org/10.1183/23120541.00328-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073410/
https://www.ncbi.nlm.nih.gov/pubmed/32201683
http://dx.doi.org/10.1183/23120541.00328-2019

Ejemplares similares